Pfizer (PFE) chairman and CEO Albert Bourla joins Julie Hyman on Market Domination to talk more about the pharmaceutical giant’s progress in developing a GLP-1 weight-loss drug and its current injectable product portfolio.
Also catch Yahoo Finance’s full interview with Albert Bourla.
To watch more expert insights and analysis on the latest market action, check out more Market Domination.







